Einfache Umwandlung von(–)-(R)-3-Hydroxybuttersäure in das (+)-(S)-Enantiomere und dessen Lacton(‒)-(S)-4-Methyloxetan-2-on

Simple Conversion of (R)-3-Hydroxybutanoic Acid to the (S)-Enantiomer and its Lactone (–)-(S)-4-Methylixetan-2-one Condensation of ( R )-3-hydroxybutanoic acid (1) with ethyl orthoacetate gives a 2-ethoxy-substituted (1,3)dioxanone 2 which is thermally labile: at ca. 100°, two competing processes commence, one leading to ethyl ( R )-3-acetoxybutanoate ( 3 ), the other one - with complete inversion of configuration - to the ( S )-4-methylixetan-2-one ( 4 ) and ethyl acetate. These can be readily separated by fractional distillation. Thus, enantiomerically pure ( S )-3-hydroxybutanoic acid (ent- 1 ) and l-2-alkyl-3-hydroxybutanoic-acid derivatives (such as 6 and 8 ) become available from the biopolymer PHB, the precursor to the acid 1 .     

Synthesis of (<Emphasis Type="Italic">E</Emphasis>)- and (<Emphasis Type="Italic">Z</Emphasis>)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles

Abstract  An efficient synthesis method for the preparation of a series of new (Z)- and (E)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles was developed. The reaction of (Z)- and (E)-3-styrylchromones with hydrazine hydrate afforded the corresponding (Z)- and (E)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles, except for nitro derivatives, where both (Z)- and (E)-4′-nitro-3-styrylchromones afforded (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles. The reaction mechanism for these transformations is discussed and the stereochemistries of all products were established by NMR experiments. Graphical abstract        

Synthèse du méthanesulfonate de (pyrimidyl-2)-1-(méthylène)-(dioxy-3, 4-benzyl)-4-pipérazinium (Piribedil) marqué au 14C

The synthesis of crystalline 1-(2-pyrimidyl)-4-(3, 4-methylenedioxybenzyl)-piperazin methanesulfonate (ET 495) labelled with ¹⁴C fixed on the piperazine nitrogen N(4) has been realized in five steps from barium carbonate ¹⁴C; Specific activity of the final product: 32,8 mCi/mmol (110 m?Ci/mg); radiochemical purity: around 99%. The mass spectrum of the labelled compound is in agreement with the chemical structure and the labelling position expected.     

Smectic A and smectic C materials: partially deuteriated chiral liquid crystals (S)-(-)-2-methylbuty 4-(4-(d13)-hexyloxyphenyl)benzoate and (S)-(-)-2-methylbutyl 4-(4-(d17)-octyloxyphenyl)benzoate

In order to study the difference in microscopic orientation of ferro- and antiferroelectric liquid crystalline molecules, we synthesized the partially deuteriated chiral compounds, (S)-(^-)-2-methylbutyl 4-(4-(d₁₃)-hexyloxy- and (S)-(^-)-2-methylbutyl 4-(4-(d₁₇)-octyloxy-phenyl)benzoates. Fundamental physical properties such as phase transition temperatures, spontaneous polarization and tilt angle were determined. Polarized FTIR measurements were also made to provide information on molecular structure and orientation.     

Synthesis and Characterisation of N,N′-Disubstituted 1,2-phenylenebis(amido)tin(II) Compounds; X-Ray structures of 1,2- and of [1,2- (tmeda)

Cyclic bis(amido)tin(II) compounds 1,2- [R = SiMe₃] ( 4 ), SiMe₂Bu^t ( 5 ) and CH₂Bu^t ( 6 )], as well as ( 4 )₂(μ-tmeda) 7 have been obtained either from (i) the corresponding dilithium compound 1,2-C₆H₄[N(R)Li]₂ 1–3 and SnCl₂ for 4–6 , respectively, (or for 4 ) 2 1 + [Sn(μ-Cl){N(SiMe₃)₂}]₂; or (ii) 1,2-C₆H₄[N(H)R]₂ + Sn[N(SiMe₃)₂]₂ for 4–6 ; or for 7 from 4 and tmeda. Compounds 4–6 are monomeric, yellow, thermochromic (becoming redder on heating), diamagnetic, crystalline and are lipophilic and sublimable in vacuo. Compound 7 is colourless. The molecular structures of 6 and 7 have been determined from single crystal X-ray diffraction data. Compound 6 crystallises in bimolecular aggregates, in which there is a weak η-C₆ … Sn contact.     

Total Synthesis of (±)-2-Pupukeanone

(±)-2-Pupukenone ( 4 ) has been synthesized, the key step being the intramolcular Diels-Alder reaction of the intermediate 13 to 14 (42%) and 15 (14%). The bromodiene 12 has been obtained from the reaction of α-isopropylidene-γ-lactone (Scheme 2) 12 with sodium phenylselenide and subsequent esterification to 9 , oxidation and thermal elimination of which furnished 10 . Reduction of 10 with diisobutylaluminimum hydride and treatment of the resulting alcohol 11 with PBr₃ led to the required bromodiene 12 . Finally, hydrogenation of the 14 on Pt(C) in CH₃OH gave a 4:1 mixture of 2-pupukeanone ( 4 ) and epi-2-pupukeanone 16 .     

(+)-(5R,6S)-2-(1′-Aminoalkyl)-6-(hydroxyalkyl)penem-3-carboxylic Acids

In continuation of our work on penem antibiotics, novel chiral (5R,6S)-2-(1′-aminoalkyl)-6-(hydroxyalkyl)-derivatives 1 have been synthesized by two essentially different strategies. Whereas the starting materials for 1a - f , azetidinones 2 and 5 , were obtained from chiral building blocks (6-aminopenicillanic acid and L-threonine, resp.), the one for 1g , azetidinone 9 , was derived from racemic 4-acetoxyazetidinone and, as chiral auxiliary, (2R)-2-mercaptopropan-1-ol. The 2-aminomethyl derivatives 1a (CGP 30 779) and 1f (CGP 31 608) proved the most potent compounds in the antibacterial tests in vitro and showed a well-balanced spectrum of activity by comparison with that of established β-lactams.     

Oximation of 2-(R<Superscript>1</Superscript>-Amino)-4-(R<Superscript>2</Superscript>-imino)naphthalen-1(4<Emphasis Type="Italic">H</Emphasis>)-ones

The oximation of 2-(R¹-amino)-4-(R²-imino)naphthalen-1(4H)-ones with hydroxylamine hydrochloride in pyridine afforded 2-(R-amino)-4-(hydroxyimino)naphthalen-1(4H)-ones.     

Synthesis of (E)- and (Z)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles

Abstract  

An efficient synthesis method for the preparation of a series of new (Z)- and (E)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles was developed. The reaction of (Z)- and (E)-3-styrylchromones with hydrazine hydrate afforded the corresponding (Z)- and (E)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles, except for nitro derivatives, where both (Z)- and (E)-4′-nitro-3-styrylchromones afforded (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles. The reaction mechanism for these transformations is discussed and the stereochemistries of all products were established by NMR experiments.     

Novel (E)- and (Z)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles from (E)- and (Z)-3-styrylchromones: the unexpected case of (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles

An efficient synthetic method for the preparation of (E)- and (Z)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles has been developed. The reaction of (E)- and (Z)-3-styrylchromones with hydrazine hydrate afforded the corresponding (E)- and (Z)-4-styrylpyrazoles, respectively, saved 4′-nitro-derivatives where both (E)- and (Z)-4′-nitro-3-styrylchromones afforded (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles. The reaction mechanism for these transformations was discussed and the stereochemistry of all products was assigned by NMR experiments.     

Synthesis of (±)-(E,E)-2,7-Dimethylocta-2,4-dienedioic Acid

(±-(2E,4E)-2,7-Dimethylocta-2,4-dienedioic acid ( 1 ) was synthesized efficiently from furan, employing a rhodium-carbenoid-induced furan-ring-unravelling reaction followed by an unusual NaBH₄/CeCl₃⋅7 H₂O reduction, Wittig-Horner olefination, and diester hydrolysis.     

Crystallographic characterization of three cathinone hydrochlorides new on the NPS market: 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one (4-MPHP), 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-PiHP) and 2-(methylamino)-1-(4-methylphenyl)pentan-1-one (4-MPD)

Cathinones belong to a group of compounds of great interest in the new psychoactive substances (NPS) market. Constant changes to the chemical structure made by the producers of these compounds require a quick reaction from analytical laboratories in ascertaining their characteristics. In this article, three cathinone derivatives were characterized by X-ray crystallography. The investigated compounds were confirmed as: 1-[1-(4-methylphenyl)-1-oxohexan-2-yl]pyrrolidin-1-ium chloride ( 1 , C₁₇H₂₆NO⁺·Cl^?, the hydrochloride of 4-MPHP), 1-(4-methyl-1-oxo-1-phenylpentan-2-yl)pyrrolidin-1-ium chloride ( 2 ; C₁₆H₂₄NO⁺·Cl^?, the hydrochloride of α-PiHP) and methyl[1-(4-methylphenyl)-1-oxopentan-2-yl]azanium chloride ( 3 ; C₁₃H₂₀NO⁺·Cl^?, the hydrochloride of 4-MPD). All the salts crystallize in a monoclinic space group: 1 and 2 in P2₁/c, and 3 in P2₁/n. To the best of our knowledge, this study provides the first detailed and comprehensive crystallographic data on salts 1 – 3 .     

Reduction of (<Emphasis Type="Italic">E</Emphasis>)-3-aryl-2-(thiazol-2-yl)acrylonitriles with lithium aluminum hydride

Reduction of (E)-3-aryl-2-(4-arylthiazol-2-yl)acrylonitriles with lithium aluminum hydride in dry ether afforded (Z)-1-amino-3-aryl-2-(thiazol-2-yl)prop-1-ene derivatives in 15 to 40% yields. The structure of (Z)-1-amino-3-(2-chlorophenyl)-2-[4-(4-methylphenyl)thiazol-2-yl]prop-1-ene was confirmed by X-ray diffraction analysis. Dedicated to Academician N. K. Kochetkov on the occasion of his 90th birthday. __________ Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 5, pp. 1301–1303, May, 2005.     

An equilibrium analysis of the aqueous H+-MoO4(2-)-(HP)O(3)2- and H+-MoO4(2-)-(HP)O(3)2--HPO4(2-) systems

The speciation in the phosphitomolybdate system, H+-MoO4(2-)-(HP)O(3)2-, has been determined from combined potentiometric and 31P NMR measurements in 0.600 M Na(Cl) medium at 298(1) K. Potentiometric titration data were collected in the ranges 2.5<-log[H+]<6.2, 40.0相似文献   

Synthesis,and Solution and Solid-State Structures of (η3-Allyl){(4S)-4-benzyl-2-[2′-(diphenylphosphino)phenyl]- 4,5-dihydrooxazole-P,N}palladium(II) Hexafluorophosphates. Comparison with Dichloro{(4S)-2-[2′-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole-P,N}zinc(II)

Crystal and solution structures of the [Pd^II(η³-allyl)] and of the [Pd^II(η³-1,3-diphenylallyl)] complexes, 4 and 5 , respectively, with (4S)-4-benzyl-2-[2′-(diphenylphosphino)phenyl]-4,5-dihydrooxazole ( 3 ) were determined by X-ray crystallography and 2D-NMR spectroscopy. Complex 4 proved to be disordered with both diastereoisomeric complexes in the crystal. The results of X-ray and NMR experiments demonstrate a good agreement between solution and solid-state equilibria of the two isomers. A comparison with dichloro{(4S)-2-[2′-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole-P,N}zinc(II) ( 2b ) shows a surprising conformational stability of the coordinated phosphinooxazole ligand 3 .     

Preparation and Structure of (E)-1-(3′-Hydroxy-2-Furanyl)-3-(3″-Hydroxy-4″-Methoxyphenyl)-2-Propen-1-One

Abstract

A facile procedure is presented for the synthesis of (E)-1-(3′-hydroxy-2′-furanyl)-3-(3″-hydroxy-4″-methoxyphenyl)-2- propen-1-one (6). Galactosylisomaltol (1) was condensed with isovanillin (2) under strong alkaline conditions at 25 [ddot]C to form (E)-1-(3′-O-β-D-galactopyranosyloxy-2′-furanyl)-3-(3″- hydroxy-4″-methoxyphenyl)-2-propen-1-one (4). (E)-1-(3′-hydroxy-2′-furanyl)-3-(3″-hydroxy-4″-methoxyphenyl)-2-propen-1-one (6) was obtained by acid hydrolysis of 4 in a 53.9% yield. This hetero-cyclic 2-propen-1-one was characterized on the basis of spectral data (IR and ¹H NMR), physicochemical properties, and conversion to a mono-O-acetyl derivative.     

Some reactions of 2-(4-substitutedphenyl)-2-(N-methyl-N-4-substitutedbenzamido) acetic acids

In situ generated 2,4-diaryl substituted münchnones from 2-(4-substitutedphenyl)-2-(N-methyl-N-4-substitutedbenzamido)acetic acids react with acetic anhydride in the presence of 2-nitromethylene thiazolidine, which is most likely acting as a base, and unexpectedly undergo a Dakin–West type reaction and a concurrent autoxidation reaction leading to the formation of (E)-1-(N,4-dimethylbenzamido)-1-(4-fluorophenyl)prop-1-en-2-yl acetate, 4-substitutedphenyl-N-methyl-N-(4-substitutedbenzoyl) benzamides and p-substituted benzoic acids. In addition, a novel and efficient access to N-acyl urea derivatives is described by the reaction between 2-(4-substitutedphenyl)-2-(N-methyl-N-4-substitutedbenzamido)acetic acids and cyclohexyl, isopropyl carbodiimides in the presence of a base. The structures of all new products were identified on the basis of NMR and IR spectra, along with X-ray diffraction data and HRMS measurements.     

Synthesis of enantiopure (R)-2-(4-methoxy-3-(3-methoxypropoxy)-benzyl)-3-methylbutanoic acid—a key intermediate for the preparation of Aliskiren

The enantioselective hydrogenation of (E)-2-(4-methoxy-3-(3-methoxypropoxy)-benzylidene)-3-methylbutanoic acid (1) to (R)-2-(4-methoxy-3-(3-methoxypropoxy)-benzyl)-3-methylbutanoic acid (2)—a key intermediate in the synthesis of the pharmacologically important renin inhibitor Aliskiren—is described. The stereochemistry of the catalytic transformation has been studied using a number of homogeneous chiral Rh(I) and Ru(II) complexes bearing ferrocene-based phosphine ligands. The highest enantioselectivity for the homogeneous hydrogenation of 1 (up to 95% ee) was achieved with a [Rh(NBD)₂]BF₄ pre-catalyst (substrate/catalyst ratio 100:1, 10 bar H₂, 40 °C, in MeOH). To bring the enantioselectivity to perfection an effective method for the isolation of the enantiopure carboxylic acid is suggested likewise.     

Preparation, structural characterisation and electrochemical properties of iron(0) and tungsten(0) carbonyl complexes with 1-(diphenylphosphanyl)-1′-vinylferrocene and 1-(diphenylphosphanyl)-1′-(dimethylvinylsilyl)ferrocene as P-monodentate ligands

A new organometallic phosphanylalkene, 1-(diphenylphosphanyl)-1′-(dimethylvinylsilyl)ferrocene (2) was prepared and—together with 1-(diphenylphosphanyl)-1′-vinylferrocene (1)—studied as a ligand in iron- and tungsten-carbonyl complexes. The following complexes featuring the mentioned phosphanylalkenes as P-monodentate donors were isolated and characterised by spectral methods: [Fe(CO)₄(L-κP)] (4, L = 1; 5, L = 2) and trans-[W(CO)₄(L-κP)₂] (6, L = 1; 7, L = 2). In addition, the solid-state structures of 4 and 6 have been determined by single-crystal X-ray diffraction and the electrochemical properties of compounds 1, 2, 4 and 6 were studied by cyclic voltammetry at platinum electrode.     

EPC syntheses from bicyclic dixoanones; (−)-5-epidehydrofukinone

(?)-5-Epidehydrofukinone ((?) -15 ) has been synthesized from (2S,4aS,5S,8aS)-4a,5-dimethyl-2-(tert-butyl)-perhydro-4H-1,3-benzodioxan-4-one ( 4a ), a counpound readily available by yeast reduction of ethyl 2-oxocyclohexanecarboxylate.